Green R, Epstein J I
Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
Am J Surg Pathol. 1999 May;23(5):567-70. doi: 10.1097/00000478-199905000-00011.
Immunohistochemical stains (IHC) stains for high molecular weight cytokeratin (HMWCK) may show the presence or absence of basal cells in a small focus of atypical glands helping to establish a benign or malignant diagnosis respectively. From January 1994 to the present, we have generated intervening unstained slides on all prostate needle biopsies for potential IHC stains for HMWCK because lesions may not survive deeper sectioning into the block. Of 1105 prostate needle biopsy cases seen at Johns Hopkins from January 1994 to December 1996, IHC staining for HMWCK was initially done on 94 (8.5%). To see whether lesions would still have been present for evaluation if we did not have intervening slides, we repeated the IHC stains for HMWCK off the paraffin blocks in 74 cases for which material was available for study. Care was taken not to trim the blocks. In 52 cases, the original HMWCK helped to establish a diagnosis; in 31 of these cases the lesion was not present on repeat IHC stains from the block. Of these 31 cases, the original HMWCK from intervening unstained slides helped to establish cancer (n = 23) or a benign (n = 8) diagnosis. The use of intervening unstained slides was critical to establish a diagnosis in 31 (2.8%) of 1105 prostate needle biopsies and saved the cost of repeat biopsy ($68,200) and spared these patients from a second surgical procedure.
高分子量细胞角蛋白(HMWCK)的免疫组织化学染色(IHC)可显示非典型腺体小病灶中基底细胞的有无,分别有助于确定良性或恶性诊断。从1994年1月至今,我们对所有前列腺穿刺活检标本都制作了中间未染色的玻片,以备可能进行HMWCK的IHC染色,因为病灶可能无法在对组织块进行更深切片时存活。在1994年1月至1996年12月约翰·霍普金斯医院所见的1105例前列腺穿刺活检病例中,最初对94例(8.5%)进行了HMWCK的IHC染色。为了了解如果没有中间玻片,病灶是否仍会存在以供评估,我们对74例有材料可供研究的病例,从石蜡块上重新进行了HMWCK的IHC染色。小心不要修剪组织块。在52例中,最初的HMWCK有助于做出诊断;在这些病例中,有31例在从组织块上重复进行的IHC染色中病灶不存在。在这31例中,来自中间未染色玻片的最初HMWCK有助于确定癌症(n = 23)或良性(n = 8)诊断。在1105例前列腺穿刺活检中,有31例(2.8%)使用中间未染色玻片对于做出诊断至关重要,节省了重复活检的费用(68,200美元),并使这些患者免于二次手术。